<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1996-10-01" modified="2018-01-31" version="206">
<accession>P98160</accession>
<accession>Q16287</accession>
<accession>Q5SZI3</accession>
<accession>Q9H3V5</accession>
<name>PGBM_HUMAN</name>
<protein>
<recommendedName>
<fullName>Basement membrane-specific heparan sulfate proteoglycan core protein</fullName>
<shortName>HSPG</shortName>
</recommendedName>
<alternativeName>
<fullName>Perlecan</fullName>
<shortName>PLC</shortName>
</alternativeName>
<component>
<recommendedName>
<fullName>Endorepellin</fullName>
</recommendedName>
</component>
<component>
<recommendedName>
<fullName>LG3 peptide</fullName>
</recommendedName>
</component>
</protein>
<gene>
<name type="primary">HSPG2</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1992" name="J. Biol. Chem." volume="267" first="8544" last="8557">
<title>Primary structure of the human heparan sulfate proteoglycan from basement membrane (HSPG2/perlecan). A chimeric molecule with multiple domains homologous to the low density lipoprotein receptor, laminin, neural cell adhesion molecules, and epidermal growth factor.</title>
<authorList>
<person name="Murdoch A.D."/>
<person name="Dodge G.R."/>
<person name="Cohen I."/>
<person name="Tuan R.S."/>
<person name="Iozzo R.V."/>
</authorList>
<dbReference type="PubMed" id="1569102"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>VARIANTS VAL-638; SER-765 AND VAL-1503</scope>
<source>
<tissue>Colon</tissue>
<tissue>Skin</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="1992" name="J. Cell Biol." volume="116" first="559" last="571">
<title>Human basement membrane heparan sulfate proteoglycan core protein: a 467-kD protein containing multiple domains resembling elements of the low density lipoprotein receptor, laminin, neural cell adhesion molecules, and epidermal growth factor.</title>
<authorList>
<person name="Kallunki P."/>
<person name="Tryggvason K."/>
</authorList>
<dbReference type="PubMed" id="1730768"/>
<dbReference type="DOI" id="10.1083/jcb.116.2.559"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>VARIANTS VAL-638; SER-765; VAL-1503; HIS-2980; GLY-2995; THR-3168 AND GLN-3632</scope>
</reference>
<reference key="3">
<citation type="journal article" date="2006" name="Nature" volume="441" first="315" last="321">
<title>The DNA sequence and biological annotation of human chromosome 1.</title>
<authorList>
<person name="Gregory S.G."/>
<person name="Barlow K.F."/>
<person name="McLay K.E."/>
<person name="Kaul R."/>
<person name="Swarbreck D."/>
<person name="Dunham A."/>
<person name="Scott C.E."/>
<person name="Howe K.L."/>
<person name="Woodfine K."/>
<person name="Spencer C.C.A."/>
<person name="Jones M.C."/>
<person name="Gillson C."/>
<person name="Searle S."/>
<person name="Zhou Y."/>
<person name="Kokocinski F."/>
<person name="McDonald L."/>
<person name="Evans R."/>
<person name="Phillips K."/>
<person name="Atkinson A."/>
<person name="Cooper R."/>
<person name="Jones C."/>
<person name="Hall R.E."/>
<person name="Andrews T.D."/>
<person name="Lloyd C."/>
<person name="Ainscough R."/>
<person name="Almeida J.P."/>
<person name="Ambrose K.D."/>
<person name="Anderson F."/>
<person name="Andrew R.W."/>
<person name="Ashwell R.I.S."/>
<person name="Aubin K."/>
<person name="Babbage A.K."/>
<person name="Bagguley C.L."/>
<person name="Bailey J."/>
<person name="Beasley H."/>
<person name="Bethel G."/>
<person name="Bird C.P."/>
<person name="Bray-Allen S."/>
<person name="Brown J.Y."/>
<person name="Brown A.J."/>
<person name="Buckley D."/>
<person name="Burton J."/>
<person name="Bye J."/>
<person name="Carder C."/>
<person name="Chapman J.C."/>
<person name="Clark S.Y."/>
<person name="Clarke G."/>
<person name="Clee C."/>
<person name="Cobley V."/>
<person name="Collier R.E."/>
<person name="Corby N."/>
<person name="Coville G.J."/>
<person name="Davies J."/>
<person name="Deadman R."/>
<person name="Dunn M."/>
<person name="Earthrowl M."/>
<person name="Ellington A.G."/>
<person name="Errington H."/>
<person name="Frankish A."/>
<person name="Frankland J."/>
<person name="French L."/>
<person name="Garner P."/>
<person name="Garnett J."/>
<person name="Gay L."/>
<person name="Ghori M.R.J."/>
<person name="Gibson R."/>
<person name="Gilby L.M."/>
<person name="Gillett W."/>
<person name="Glithero R.J."/>
<person name="Grafham D.V."/>
<person name="Griffiths C."/>
<person name="Griffiths-Jones S."/>
<person name="Grocock R."/>
<person name="Hammond S."/>
<person name="Harrison E.S.I."/>
<person name="Hart E."/>
<person name="Haugen E."/>
<person name="Heath P.D."/>
<person name="Holmes S."/>
<person name="Holt K."/>
<person name="Howden P.J."/>
<person name="Hunt A.R."/>
<person name="Hunt S.E."/>
<person name="Hunter G."/>
<person name="Isherwood J."/>
<person name="James R."/>
<person name="Johnson C."/>
<person name="Johnson D."/>
<person name="Joy A."/>
<person name="Kay M."/>
<person name="Kershaw J.K."/>
<person name="Kibukawa M."/>
<person name="Kimberley A.M."/>
<person name="King A."/>
<person name="Knights A.J."/>
<person name="Lad H."/>
<person name="Laird G."/>
<person name="Lawlor S."/>
<person name="Leongamornlert D.A."/>
<person name="Lloyd D.M."/>
<person name="Loveland J."/>
<person name="Lovell J."/>
<person name="Lush M.J."/>
<person name="Lyne R."/>
<person name="Martin S."/>
<person name="Mashreghi-Mohammadi M."/>
<person name="Matthews L."/>
<person name="Matthews N.S.W."/>
<person name="McLaren S."/>
<person name="Milne S."/>
<person name="Mistry S."/>
<person name="Moore M.J.F."/>
<person name="Nickerson T."/>
<person name="O'Dell C.N."/>
<person name="Oliver K."/>
<person name="Palmeiri A."/>
<person name="Palmer S.A."/>
<person name="Parker A."/>
<person name="Patel D."/>
<person name="Pearce A.V."/>
<person name="Peck A.I."/>
<person name="Pelan S."/>
<person name="Phelps K."/>
<person name="Phillimore B.J."/>
<person name="Plumb R."/>
<person name="Rajan J."/>
<person name="Raymond C."/>
<person name="Rouse G."/>
<person name="Saenphimmachak C."/>
<person name="Sehra H.K."/>
<person name="Sheridan E."/>
<person name="Shownkeen R."/>
<person name="Sims S."/>
<person name="Skuce C.D."/>
<person name="Smith M."/>
<person name="Steward C."/>
<person name="Subramanian S."/>
<person name="Sycamore N."/>
<person name="Tracey A."/>
<person name="Tromans A."/>
<person name="Van Helmond Z."/>
<person name="Wall M."/>
<person name="Wallis J.M."/>
<person name="White S."/>
<person name="Whitehead S.L."/>
<person name="Wilkinson J.E."/>
<person name="Willey D.L."/>
<person name="Williams H."/>
<person name="Wilming L."/>
<person name="Wray P.W."/>
<person name="Wu Z."/>
<person name="Coulson A."/>
<person name="Vaudin M."/>
<person name="Sulston J.E."/>
<person name="Durbin R.M."/>
<person name="Hubbard T."/>
<person name="Wooster R."/>
<person name="Dunham I."/>
<person name="Carter N.P."/>
<person name="McVean G."/>
<person name="Ross M.T."/>
<person name="Harrow J."/>
<person name="Olson M.V."/>
<person name="Beck S."/>
<person name="Rogers J."/>
<person name="Bentley D.R."/>
</authorList>
<dbReference type="PubMed" id="16710414"/>
<dbReference type="DOI" id="10.1038/nature04727"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="4">
<citation type="journal article" date="1993" name="Proc. Natl. Acad. Sci. U.S.A." volume="90" first="10404" last="10408">
<title>Structural characterization of the complete human perlecan gene and its promoter.</title>
<authorList>
<person name="Cohen I.R."/>
<person name="Graessel S."/>
<person name="Murdoch A.D."/>
<person name="Iozzo R.V."/>
</authorList>
<dbReference type="PubMed" id="8234307"/>
<dbReference type="DOI" id="10.1073/pnas.90.21.10404"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-21</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2000" name="Nat. Genet." volume="26" first="480" last="483">
<title>Perlecan, the major proteoglycan of basement membranes, is altered in patients with Schwartz-Jampel syndrome (chondrodystrophic myotonia).</title>
<authorList>
<person name="Nicole S."/>
<person name="Davoine C.-S."/>
<person name="Topaloglu H."/>
<person name="Cattolico L."/>
<person name="Barral D."/>
<person name="Beighton P."/>
<person name="Ben-Hamida C."/>
<person name="Hammouda H."/>
<person name="Cruaud C."/>
<person name="White P.S."/>
<person name="Samson D."/>
<person name="Urtizberea J.A."/>
<person name="Lehmann-Horn F."/>
<person name="Weissenbach J."/>
<person name="Hentati F."/>
<person name="Fontaine B."/>
</authorList>
<dbReference type="PubMed" id="11101850"/>
<dbReference type="DOI" id="10.1038/82638"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 22-4391</scope>
<scope>VARIANTS VAL-638 AND SJS1 TYR-1532</scope>
<scope>VARIANTS SER-765 AND VAL-1503</scope>
</reference>
<reference key="6">
<citation type="journal article" date="1991" name="Genomics" volume="11" first="389" last="396">
<title>Cloning of human heparan sulfate proteoglycan core protein, assignment of the gene (HSPG2) to 1p36.1-->p35 and identification of a BamHI restriction fragment length polymorphism.</title>
<authorList>
<person name="Kallunki P."/>
<person name="Eddy R.L."/>
<person name="Byers M.G."/>
<person name="Kestila M."/>
<person name="Shows T.B."/>
<person name="Tryggvason K."/>
</authorList>
<dbReference type="PubMed" id="1685141"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 890-1396</scope>
<source>
<tissue>Fibrosarcoma</tissue>
</source>
</reference>
<reference key="7">
<citation type="journal article" date="1991" name="Genomics" volume="10" first="673" last="680">
<title>Heparan sulfate proteoglycan of human colon: partial molecular cloning, cellular expression, and mapping of the gene (HSPG2) to the short arm of human chromosome 1.</title>
<authorList>
<person name="Dodge G.R."/>
<person name="Kovalszky I."/>
<person name="Chu M.-L."/>
<person name="Hassell J.R."/>
<person name="McBride O.W."/>
<person name="Yi H.F."/>
<person name="Iozzo R.V."/>
</authorList>
<dbReference type="PubMed" id="1679749"/>
<dbReference type="DOI" id="10.1016/0888-7543(91)90451-J"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 1016-1470</scope>
<source>
<tissue>Colon</tissue>
</source>
</reference>
<reference key="8">
<citation type="journal article" date="1989" name="J. Cell Biol." volume="109" first="3199" last="3211">
<title>Matrix-associated heparan sulfate proteoglycan: core protein-specific monoclonal antibodies decorate the pericellular matrix of connective tissue cells and the stromal side of basement membranes.</title>
<authorList>
<person name="Heremans A."/>
<person name="van der Schueren B."/>
<person name="de Cock B."/>
<person name="Paulsson M."/>
<person name="Cassiman J.-J."/>
<person name="van den Berghe H."/>
<person name="David G."/>
</authorList>
<dbReference type="PubMed" id="2687294"/>
<dbReference type="DOI" id="10.1083/jcb.109.6.3199"/>
</citation>
<scope>PROTEIN SEQUENCE OF 1379-1398 AND 2259-2278</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2005" name="J. Biol. Chem." volume="280" first="7080" last="7087">
<title>BMP-1/Tolloid-like metalloproteases process endorepellin, the angiostatic C-terminal fragment of perlecan.</title>
<authorList>
<person name="Gonzalez E.M."/>
<person name="Reed C.C."/>
<person name="Bix G."/>
<person name="Fu J."/>
<person name="Zhang Y."/>
<person name="Gopalakrishnan B."/>
<person name="Greenspan D.S."/>
<person name="Iozzo R.V."/>
</authorList>
<dbReference type="PubMed" id="15591058"/>
<dbReference type="DOI" id="10.1074/jbc.M409841200"/>
</citation>
<scope>PROTEIN SEQUENCE OF 4197-4208</scope>
<scope>PROTEOLYTIC PROCESSING AT ASN-4196</scope>
<scope>FUNCTION OF LG3 PEPTIDE</scope>
<scope>GLYCOSYLATION</scope>
<scope>MUTAGENESIS OF ASP-4197; ASP-4258 AND ASN-4327</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="4238" last="4249">
<title>Endorepellin, a novel inhibitor of angiogenesis derived from the C terminus of perlecan.</title>
<authorList>
<person name="Mongiat M."/>
<person name="Sweeney S.M."/>
<person name="San Antonio J.D."/>
<person name="Fu J."/>
<person name="Iozzo R.V."/>
</authorList>
<dbReference type="PubMed" id="12435733"/>
<dbReference type="DOI" id="10.1074/jbc.M210445200"/>
</citation>
<scope>PROTEIN SEQUENCE OF 4197-4203</scope>
<scope>PROTEOLYTIC PROCESSING AT ASN-4196</scope>
<scope>FUNCTION OF ENDOREPELLIN AND LG3 PEPTIDE</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2001" name="J. Biol. Chem." volume="276" first="10263" last="10271">
<title>Fibroblast growth factor-binding protein is a novel partner for perlecan protein core.</title>
<authorList>
<person name="Mongiat M."/>
<person name="Otto J."/>
<person name="Oldershaw R."/>
<person name="Ferrer F."/>
<person name="Sato J.D."/>
<person name="Iozzo R.V."/>
</authorList>
<dbReference type="PubMed" id="11148217"/>
<dbReference type="DOI" id="10.1074/jbc.M011493200"/>
</citation>
<scope>INTERACTION WITH FGFBP1</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2001" name="Nat. Genet." volume="27" first="431" last="434">
<title>Dyssegmental dysplasia, Silverman-Handmaker type, is caused by functional null mutations of the perlecan gene.</title>
<authorList>
<person name="Arikawa-Hirasawa E."/>
<person name="Wilcox W.R."/>
<person name="Le A.H."/>
<person name="Silverman N."/>
<person name="Govindraj P."/>
<person name="Hassell J.R."/>
<person name="Yamada Y."/>
</authorList>
<dbReference type="PubMed" id="11279527"/>
<dbReference type="DOI" id="10.1038/86941"/>
</citation>
<scope>INVOLVEMENT IN DDSH</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="23092" last="23099">
<title>The type XIII collagen ectodomain is a 150-nm rod and capable of binding to fibronectin, nidogen-2, perlecan, and heparin.</title>
<authorList>
<person name="Tu H."/>
<person name="Sasaki T."/>
<person name="Snellman A."/>
<person name="Gohring W."/>
<person name="Pirila P."/>
<person name="Timpl R."/>
<person name="Pihlajaniemi T."/>
</authorList>
<dbReference type="PubMed" id="11956183"/>
<dbReference type="DOI" id="10.1074/jbc.M107583200"/>
</citation>
<scope>INTERACTION WITH COL13A1</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="17491" last="17499">
<title>Perlecan protein core interacts with extracellular matrix protein 1 (ECM1), a glycoprotein involved in bone formation and angiogenesis.</title>
<authorList>
<person name="Mongiat M."/>
<person name="Fu J."/>
<person name="Oldershaw R."/>
<person name="Greenhalgh R."/>
<person name="Gown A.M."/>
<person name="Iozzo R.V."/>
</authorList>
<dbReference type="PubMed" id="12604605"/>
<dbReference type="DOI" id="10.1074/jbc.M210529200"/>
</citation>
<scope>INTERACTION WITH ECM1</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2003" name="Nat. Biotechnol." volume="21" first="660" last="666">
<title>Identification and quantification of N-linked glycoproteins using hydrazide chemistry, stable isotope labeling and mass spectrometry.</title>
<authorList>
<person name="Zhang H."/>
<person name="Li X.-J."/>
<person name="Martin D.B."/>
<person name="Aebersold R."/>
</authorList>
<dbReference type="PubMed" id="12754519"/>
<dbReference type="DOI" id="10.1038/nbt827"/>
</citation>
<scope>GLYCOSYLATION AT ASN-2121</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2005" name="J. Proteome Res." volume="4" first="2070" last="2080">
<title>Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry.</title>
<authorList>
<person name="Liu T."/>
<person name="Qian W.-J."/>
<person name="Gritsenko M.A."/>
<person name="Camp D.G. II"/>
<person name="Monroe M.E."/>
<person name="Moore R.J."/>
<person name="Smith R.D."/>
</authorList>
<dbReference type="PubMed" id="16335952"/>
<dbReference type="DOI" id="10.1021/pr0502065"/>
</citation>
<scope>GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-1755</scope>
<source>
<tissue>Plasma</tissue>
</source>
</reference>
<reference key="17">
<citation type="journal article" date="2006" name="J. Natl. Cancer Inst." volume="98" first="1634" last="1646">
<title>Endorepellin in vivo: targeting the tumor vasculature and retarding cancer growth and metabolism.</title>
<authorList>
<person name="Bix G."/>
<person name="Castello R."/>
<person name="Burrows M."/>
<person name="Zoeller J.J."/>
<person name="Weech M."/>
<person name="Iozzo R.A."/>
<person name="Cardi C."/>
<person name="Thakur M.L."/>
<person name="Barker C.A."/>
<person name="Camphausen K."/>
<person name="Iozzo R.V."/>
</authorList>
<dbReference type="PubMed" id="17105986"/>
<dbReference type="DOI" id="10.1093/jnci/djj441"/>
</citation>
<scope>FUNCTION OF ENDOREPELLIN</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2008" name="J. Biol. Chem." volume="283" first="2335" last="2343">
<title>Integrin alpha2beta1 is the required receptor for endorepellin angiostatic activity.</title>
<authorList>
<person name="Woodall B.P."/>
<person name="Nystroem A."/>
<person name="Iozzo R.A."/>
<person name="Eble J.A."/>
<person name="Niland S."/>
<person name="Krieg T."/>
<person name="Eckes B."/>
<person name="Pozzi A."/>
<person name="Iozzo R.V."/>
</authorList>
<dbReference type="PubMed" id="18024432"/>
<dbReference type="DOI" id="10.1074/jbc.M708364200"/>
</citation>
<scope>FUNCTION OF ENDOREPELLIN</scope>
<scope>IDENTIFICATION OF RECEPTOR</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2009" name="Blood" volume="114" first="4897" last="4906">
<title>Role of tyrosine phosphatase SHP-1 in the mechanism of endorepellin angiostatic activity.</title>
<authorList>
<person name="Nystrom A."/>
<person name="Shaik Z.P."/>
<person name="Gullberg D."/>
<person name="Krieg T."/>
<person name="Eckes B."/>
<person name="Zent R."/>
<person name="Pozzi A."/>
<person name="Iozzo R.V."/>
</authorList>
<dbReference type="PubMed" id="19789387"/>
<dbReference type="DOI" id="10.1182/blood-2009-02-207134"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2009" name="J. Proteome Res." volume="8" first="651" last="661">
<title>Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry.</title>
<authorList>
<person name="Chen R."/>
<person name="Jiang X."/>
<person name="Sun D."/>
<person name="Han G."/>
<person name="Wang F."/>
<person name="Ye M."/>
<person name="Wang L."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="19159218"/>
<dbReference type="DOI" id="10.1021/pr8008012"/>
</citation>
<scope>GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-554; ASN-1755; ASN-3072; ASN-3780; ASN-3836 AND ASN-4068</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="21">
<citation type="journal article" date="2012" name="Mol. Cell. Proteomics" volume="11" first="1" last="17">
<title>Human urinary glycoproteomics; attachment site specific analysis of N-and O-linked glycosylations by CID and ECD.</title>
<authorList>
<person name="Halim A."/>
<person name="Nilsson J."/>
<person name="Ruetschi U."/>
<person name="Hesse C."/>
<person name="Larson G."/>
</authorList>
<dbReference type="PubMed" id="22171320"/>
<dbReference type="DOI" id="10.1074/mcp.M111.013649"/>
</citation>
<scope>GLYCOSYLATION AT THR-42</scope>
<scope>STRUCTURE OF CARBOHYDRATES</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="23">
<citation type="journal article" date="2011" name="J. Mol. Biol." volume="414" first="231" last="242">
<title>Crystal structure of the LG3 domain of endorepellin, an angiogenesis inhibitor.</title>
<authorList>
<person name="Le B.V."/>
<person name="Kim H."/>
<person name="Choi J."/>
<person name="Kim J.H."/>
<person name="Hahn M.J."/>
<person name="Lee C."/>
<person name="Kim K.K."/>
<person name="Hwang H.Y."/>
</authorList>
<dbReference type="PubMed" id="21996443"/>
<dbReference type="DOI" id="10.1016/j.jmb.2011.09.048"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.5 ANGSTROMS) OF 4197-4391</scope>
<scope>DISULFIDE BOND</scope>
<scope>CALCIUM-BINDING SITES</scope>
</reference>
<comment type="function">
<text>Integral component of basement membranes. Component of the glomerular basement membrane (GBM), responsible for the fixed negative electrostatic membrane charge, and which provides a barrier which is both size- and charge-selective. It serves as an attachment substrate for cells. Plays essential roles in vascularization. Critical for normal heart development and for regulating the vascular response to injury. Also required for avascular cartilage development.</text>
</comment>
<comment type="function">
<text>Endorepellin in an anti-angiogenic and anti-tumor peptide that inhibits endothelial cell migration, collagen-induced endothelial tube morphogenesis and blood vessel growth in the chorioallantoic membrane. Blocks endothelial cell adhesion to fibronectin and type I collagen. Anti-tumor agent in neovascularization. Interaction with its ligand, integrin alpha2/beta1, is required for the anti-angiogenic properties. Evokes a reduction in phosphorylation of receptor tyrosine kinases via alpha2/beta1 integrin-mediated activation of the tyrosine phosphatase, PTPN6.</text>
</comment>
<comment type="function">
<text>The LG3 peptide has anti-angiogenic properties that require binding of calcium ions for full activity.</text>
</comment>
<comment type="subunit">
<text evidence="12 14 16">Purified perlecan has a strong tendency to aggregate in dimers or stellate structures. It interacts with other basement membrane components such as laminin, prolargin and collagen type IV. Interacts with COL13A1, FGFBP1 and VWA1. Interacts (via C-terminus) with ECM1 (via C-terminus).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-6896607"/>
<interactant intactId="EBI-6530464">
<id>P17948-2</id>
<label>FLT1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-947664"/>
<interactant intactId="EBI-1005487">
<id>P35968</id>
<label>KDR</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Secreted</location>
<location>extracellular space</location>
<location>extracellular matrix</location>
<location>basement membrane</location>
</subcellularLocation>
</comment>
<comment type="tissue specificity">
<text>Found in the basement membranes.</text>
</comment>
<comment type="PTM">
<text evidence="15 18">Proteolytic processing produces the C-terminal angiogenic peptide, endorepellin. This peptide can be further processed to produce the LG3 peptide.</text>
</comment>
<comment type="PTM">
<text evidence="17 18 20 22 24">N- and O-glycosylated. O-glycosylated with core 1 or possibly core 8 glycans. Perlecan contains three heparan sulfate chains. The LG3 peptide contains at least three and up to five potential O-glycosylation sites but no N-glycosylation.</text>
</comment>
<comment type="disease" evidence="11">
<disease id="DI-02288">
<name>Schwartz-Jampel syndrome</name>
<acronym>SJS1</acronym>
<description>Rare autosomal recessive disorder characterized by permanent myotonia (prolonged failure of muscle relaxation) and skeletal dysplasia, resulting in reduced stature, kyphoscoliosis, bowing of the diaphyses and irregular epiphyses.</description>
<dbReference type="MIM" id="255800"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="13">
<disease id="DI-01512">
<name>Dyssegmental dysplasia Silverman-Handmaker type</name>
<acronym>DDSH</acronym>
<description>The dyssegmental dysplasias are rare, autosomal recessive skeletal dysplasias with anisospondyly and micromelia. There are two recognized types: the severe, lethal DDSH and the milder Rolland-Desbuquois form. Individuals with DDSH also have a flat face, micrognathia, cleft palate and reduced joint mobility, and frequently have an encephalocoele. The endochondral growth plate is short, the calcospherites (which are spherical calcium-phosphorus crystals produced by hypertrophic chondrocytes) are unfused, and there is mucoid degeneration of the resting cartilage.</description>
<dbReference type="MIM" id="224410"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="miscellaneous">
<text>The LG3 peptide has been found in the urine of patients with end-stage renal disease and in the amniotic fluid of pregnant women with premature rupture of fetal membranes.</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/HSPG2ID40890ch1p36.html"/>
</comment>
<comment type="online information" name="Wikipedia">
<link uri="https://en.wikipedia.org/wiki/Perlecan"/>
<text>Perlecan entry</text>
</comment>
<dbReference type="EMBL" id="M85289">
<property type="protein sequence ID" value="AAA52700.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X62515">
<property type="protein sequence ID" value="CAA44373.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AL590556">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL590103">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="L22078">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL445795">
<property type="protein sequence ID" value="CAC18534.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="S76436">
<property type="protein sequence ID" value="AAB21121.2"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M64283">
<property type="protein sequence ID" value="AAA52699.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS30625.1"/>
<dbReference type="PIR" id="A38096">
<property type="entry name" value="A38096"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001278789.1">
<property type="nucleotide sequence ID" value="NM_001291860.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_005520.4">
<property type="nucleotide sequence ID" value="NM_005529.6"/>
</dbReference>
<dbReference type="UniGene" id="Hs.562227"/>
<dbReference type="PDB" id="3SH4">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.50"/>
<property type="chains" value="A=4197-4391"/>
</dbReference>
<dbReference type="PDB" id="3SH5">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A=4197-4391"/>
</dbReference>
<dbReference type="PDBsum" id="3SH4"/>
<dbReference type="PDBsum" id="3SH5"/>
<dbReference type="ProteinModelPortal" id="P98160"/>
<dbReference type="SMR" id="P98160"/>
<dbReference type="BioGrid" id="109571">
<property type="interactions" value="35"/>
</dbReference>
<dbReference type="IntAct" id="P98160">
<property type="interactions" value="30"/>
</dbReference>
<dbReference type="MINT" id="MINT-123304"/>
<dbReference type="STRING" id="9606.ENSP00000363827"/>
<dbReference type="DrugBank" id="DB00039">
<property type="generic name" value="Palifermin"/>
</dbReference>
<dbReference type="iPTMnet" id="P98160"/>
<dbReference type="PhosphoSitePlus" id="P98160"/>
<dbReference type="UniCarbKB" id="P98160"/>
<dbReference type="BioMuta" id="HSPG2"/>
<dbReference type="DMDM" id="317373536"/>
<dbReference type="DOSAC-COBS-2DPAGE" id="P98160"/>
<dbReference type="EPD" id="P98160"/>
<dbReference type="MaxQB" id="P98160"/>
<dbReference type="PaxDb" id="P98160"/>
<dbReference type="PeptideAtlas" id="P98160"/>
<dbReference type="PRIDE" id="P98160"/>
<dbReference type="Ensembl" id="ENST00000374695">
<property type="protein sequence ID" value="ENSP00000363827"/>
<property type="gene ID" value="ENSG00000142798"/>
</dbReference>
<dbReference type="GeneID" id="3339"/>
<dbReference type="KEGG" id="hsa:3339"/>
<dbReference type="UCSC" id="uc001bfj.4">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="3339"/>
<dbReference type="DisGeNET" id="3339"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000142798.17"/>
<dbReference type="GeneCards" id="HSPG2"/>
<dbReference type="H-InvDB" id="HIX0023554"/>
<dbReference type="H-InvDB" id="HIX0023598"/>
<dbReference type="HGNC" id="HGNC:5273">
<property type="gene designation" value="HSPG2"/>
</dbReference>
<dbReference type="HPA" id="CAB009820"/>
<dbReference type="HPA" id="CAB020718"/>
<dbReference type="HPA" id="HPA018892"/>
<dbReference type="MalaCards" id="HSPG2"/>
<dbReference type="MIM" id="142461">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="224410">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="255800">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P98160"/>
<dbReference type="OpenTargets" id="ENSG00000142798"/>
<dbReference type="Orphanet" id="1865">
<property type="disease" value="Dyssegmental dysplasia, Silverman-Handmaker type"/>
</dbReference>
<dbReference type="Orphanet" id="800">
<property type="disease" value="Schwartz-Jampel syndrome"/>
</dbReference>
<dbReference type="PharmGKB" id="PA29537"/>
<dbReference type="eggNOG" id="KOG3509">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG410XTD2">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00860000133679"/>
<dbReference type="HOGENOM" id="HOG000049276"/>
<dbReference type="HOVERGEN" id="HBG008174"/>
<dbReference type="InParanoid" id="P98160"/>
<dbReference type="KO" id="K06255"/>
<dbReference type="OMA" id="TEGPQCN"/>
<dbReference type="OrthoDB" id="EOG091G048M"/>
<dbReference type="PhylomeDB" id="P98160"/>
<dbReference type="TreeFam" id="TF326548"/>
<dbReference type="Reactome" id="R-HSA-1474228">
<property type="pathway name" value="Degradation of the extracellular matrix"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1971475">
<property type="pathway name" value="A tetrasaccharide linker sequence is required for GAG synthesis"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2022928">
<property type="pathway name" value="HS-GAG biosynthesis"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2024096">
<property type="pathway name" value="HS-GAG degradation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-216083">
<property type="pathway name" value="Integrin cell surface interactions"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-3000157">
<property type="pathway name" value="Laminin interactions"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-3000171">
<property type="pathway name" value="Non-integrin membrane-ECM interactions"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-3560783">
<property type="pathway name" value="Defective B4GALT7 causes EDS, progeroid type"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-3560801">
<property type="pathway name" value="Defective B3GAT3 causes JDSSDHD"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-3656237">
<property type="pathway name" value="Defective EXT2 causes exostoses 2"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-3656253">
<property type="pathway name" value="Defective EXT1 causes exostoses 1, TRPS2 and CHDS"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-4420332">
<property type="pathway name" value="Defective B3GALT6 causes EDSP2 and SEMDJL1"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-975634">
<property type="pathway name" value="Retinoid metabolism and transport"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-977225">
<property type="pathway name" value="Amyloid fiber formation"/>
</dbReference>
<dbReference type="SIGNOR" id="P98160"/>
<dbReference type="ChiTaRS" id="HSPG2">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="GeneWiki" id="Perlecan"/>
<dbReference type="GenomeRNAi" id="3339"/>
<dbReference type="PRO" id="PR:P98160"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 1"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000142798"/>
<dbReference type="CleanEx" id="HS_HSPG2"/>
<dbReference type="ExpressionAtlas" id="P98160">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P98160">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005604">
<property type="term" value="C:basement membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0070062">
<property type="term" value="C:extracellular exosome"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031012">
<property type="term" value="C:extracellular matrix"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005576">
<property type="term" value="C:extracellular region"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005615">
<property type="term" value="C:extracellular space"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005925">
<property type="term" value="C:focal adhesion"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005796">
<property type="term" value="C:Golgi lumen"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0043202">
<property type="term" value="C:lysosomal lumen"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0098797">
<property type="term" value="C:plasma membrane protein complex"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005509">
<property type="term" value="F:calcium ion binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0005178">
<property type="term" value="F:integrin binding"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0050750">
<property type="term" value="F:low-density lipoprotein particle receptor binding"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0008022">
<property type="term" value="F:protein C-terminus binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001525">
<property type="term" value="P:angiogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0007420">
<property type="term" value="P:brain development"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0072358">
<property type="term" value="P:cardiovascular system development"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0030154">
<property type="term" value="P:cell differentiation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0016049">
<property type="term" value="P:cell growth"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0044267">
<property type="term" value="P:cellular protein metabolic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0022617">
<property type="term" value="P:extracellular matrix disassembly"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0030198">
<property type="term" value="P:extracellular matrix organization"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006024">
<property type="term" value="P:glycosaminoglycan biosynthetic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006027">
<property type="term" value="P:glycosaminoglycan catabolic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0030203">
<property type="term" value="P:glycosaminoglycan metabolic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006954">
<property type="term" value="P:inflammatory response"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0006629">
<property type="term" value="P:lipid metabolic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1905907">
<property type="term" value="P:negative regulation of amyloid fibril formation"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0016525">
<property type="term" value="P:negative regulation of angiogenesis"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0060548">
<property type="term" value="P:negative regulation of cell death"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0006898">
<property type="term" value="P:receptor-mediated endocytosis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0001523">
<property type="term" value="P:retinoid metabolic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="CDD" id="cd00112">
<property type="entry name" value="LDLa"/>
<property type="match status" value="4"/>
</dbReference>
<dbReference type="Gene3D" id="2.60.40.10">
<property type="match status" value="21"/>
</dbReference>
<dbReference type="InterPro" id="IPR013320">
<property type="entry name" value="ConA-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR001881">
<property type="entry name" value="EGF-like_Ca-bd_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR013032">
<property type="entry name" value="EGF-like_CS"/>
</dbReference>
<dbReference type="InterPro" id="IPR000742">
<property type="entry name" value="EGF-like_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR007110">
<property type="entry name" value="Ig-like_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR036179">
<property type="entry name" value="Ig-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR013783">
<property type="entry name" value="Ig-like_fold"/>
</dbReference>
<dbReference type="InterPro" id="IPR013098">
<property type="entry name" value="Ig_I-set"/>
</dbReference>
<dbReference type="InterPro" id="IPR003599">
<property type="entry name" value="Ig_sub"/>
</dbReference>
<dbReference type="InterPro" id="IPR003598">
<property type="entry name" value="Ig_sub2"/>
</dbReference>
<dbReference type="InterPro" id="IPR013106">
<property type="entry name" value="Ig_V-set"/>
</dbReference>
<dbReference type="InterPro" id="IPR002049">
<property type="entry name" value="Laminin_EGF"/>
</dbReference>
<dbReference type="InterPro" id="IPR001791">
<property type="entry name" value="Laminin_G"/>
</dbReference>
<dbReference type="InterPro" id="IPR000034">
<property type="entry name" value="Laminin_IV"/>
</dbReference>
<dbReference type="InterPro" id="IPR036055">
<property type="entry name" value="LDL_receptor-like_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR023415">
<property type="entry name" value="LDLR_class-A_CS"/>
</dbReference>
<dbReference type="InterPro" id="IPR002172">
<property type="entry name" value="LDrepeatLR_classA_rpt"/>
</dbReference>
<dbReference type="InterPro" id="IPR000082">
<property type="entry name" value="SEA_dom"/>
</dbReference>
<dbReference type="Pfam" id="PF00008">
<property type="entry name" value="EGF"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="Pfam" id="PF07679">
<property type="entry name" value="I-set"/>
<property type="match status" value="9"/>
</dbReference>
<dbReference type="Pfam" id="PF13895">
<property type="entry name" value="Ig_2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00052">
<property type="entry name" value="Laminin_B"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="Pfam" id="PF00053">
<property type="entry name" value="Laminin_EGF"/>
<property type="match status" value="9"/>
</dbReference>
<dbReference type="Pfam" id="PF00054">
<property type="entry name" value="Laminin_G_1"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="Pfam" id="PF00057">
<property type="entry name" value="Ldl_recept_a"/>
<property type="match status" value="4"/>
</dbReference>
<dbReference type="PRINTS" id="PR00261">
<property type="entry name" value="LDLRECEPTOR"/>
</dbReference>
<dbReference type="SMART" id="SM00181">
<property type="entry name" value="EGF"/>
<property type="match status" value="11"/>
</dbReference>
<dbReference type="SMART" id="SM00179">
<property type="entry name" value="EGF_CA"/>
<property type="match status" value="5"/>
</dbReference>
<dbReference type="SMART" id="SM00180">
<property type="entry name" value="EGF_Lam"/>
<property type="match status" value="9"/>
</dbReference>
<dbReference type="SMART" id="SM00409">
<property type="entry name" value="IG"/>
<property type="match status" value="22"/>
</dbReference>
<dbReference type="SMART" id="SM00408">
<property type="entry name" value="IGc2"/>
<property type="match status" value="22"/>
</dbReference>
<dbReference type="SMART" id="SM00406">
<property type="entry name" value="IGv"/>
<property type="match status" value="8"/>
</dbReference>
<dbReference type="SMART" id="SM00281">
<property type="entry name" value="LamB"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="SMART" id="SM00282">
<property type="entry name" value="LamG"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="SMART" id="SM00192">
<property type="entry name" value="LDLa"/>
<property type="match status" value="4"/>
</dbReference>
<dbReference type="SMART" id="SM00200">
<property type="entry name" value="SEA"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF48726">
<property type="entry name" value="SSF48726"/>
<property type="match status" value="22"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF49899">
<property type="entry name" value="SSF49899"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF57424">
<property type="entry name" value="SSF57424"/>
<property type="match status" value="4"/>
</dbReference>
<dbReference type="PROSITE" id="PS00022">
<property type="entry name" value="EGF_1"/>
<property type="match status" value="9"/>
</dbReference>
<dbReference type="PROSITE" id="PS01186">
<property type="entry name" value="EGF_2"/>
<property type="match status" value="6"/>
</dbReference>
<dbReference type="PROSITE" id="PS50026">
<property type="entry name" value="EGF_3"/>
<property type="match status" value="4"/>
</dbReference>
<dbReference type="PROSITE" id="PS01248">
<property type="entry name" value="EGF_LAM_1"/>
<property type="match status" value="11"/>
</dbReference>
<dbReference type="PROSITE" id="PS50027">
<property type="entry name" value="EGF_LAM_2"/>
<property type="match status" value="8"/>
</dbReference>
<dbReference type="PROSITE" id="PS50835">
<property type="entry name" value="IG_LIKE"/>
<property type="match status" value="22"/>
</dbReference>
<dbReference type="PROSITE" id="PS50025">
<property type="entry name" value="LAM_G_DOMAIN"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="PROSITE" id="PS51115">
<property type="entry name" value="LAMININ_IVA"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="PROSITE" id="PS01209">
<property type="entry name" value="LDLRA_1"/>
<property type="match status" value="4"/>
</dbReference>
<dbReference type="PROSITE" id="PS50068">
<property type="entry name" value="LDLRA_2"/>
<property type="match status" value="4"/>
</dbReference>
<dbReference type="PROSITE" id="PS50024">
<property type="entry name" value="SEA"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0037">Angiogenesis</keyword>
<keyword id="KW-0084">Basement membrane</keyword>
<keyword id="KW-0106">Calcium</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0245">EGF-like domain</keyword>
<keyword id="KW-0272">Extracellular matrix</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0357">Heparan sulfate</keyword>
<keyword id="KW-0393">Immunoglobulin domain</keyword>
<keyword id="KW-0424">Laminin EGF-like domain</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-0654">Proteoglycan</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0964">Secreted</keyword>
<keyword id="KW-0732">Signal</keyword>
<feature type="signal peptide" evidence="4">
<location>
<begin position="1"/>
<end position="21"/>
</location>
</feature>
<feature type="chain" description="Basement membrane-specific heparan sulfate proteoglycan core protein" id="PRO_0000026696">
<location>
<begin position="22"/>
<end position="4391"/>
</location>
</feature>
<feature type="chain" description="Endorepellin" id="PRO_0000391621">
<location>
<begin position="3687"/>
<end position="4391"/>
</location>
</feature>
<feature type="chain" description="LG3 peptide" id="PRO_0000391622">
<location>
<begin position="4197"/>
<end position="4391"/>
</location>
</feature>
<feature type="domain" description="SEA" evidence="8">
<location>
<begin position="80"/>
<end position="191"/>
</location>
</feature>
<feature type="domain" description="LDL-receptor class A 1" evidence="7">
<location>
<begin position="198"/>
<end position="235"/>
</location>
</feature>
<feature type="domain" description="LDL-receptor class A 2" evidence="7">
<location>
<begin position="284"/>
<end position="320"/>
</location>
</feature>
<feature type="domain" description="LDL-receptor class A 3" evidence="7">
<location>
<begin position="324"/>
<end position="360"/>
</location>
</feature>
<feature type="domain" description="LDL-receptor class A 4" evidence="7">
<location>
<begin position="367"/>
<end position="404"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 1">
<location>
<begin position="405"/>
<end position="504"/>
</location>
</feature>
<feature type="domain" description="Laminin EGF-like 1; first part" evidence="10">
<location>
<begin position="521"/>
<end position="530"/>
</location>
</feature>
<feature type="domain" description="Laminin IV type A 1" evidence="9">
<location>
<begin position="538"/>
<end position="730"/>
</location>
</feature>
<feature type="domain" description="Laminin EGF-like 1; second part" evidence="10">
<location>
<begin position="731"/>
<end position="763"/>
</location>
</feature>
<feature type="domain" description="Laminin EGF-like 2" evidence="10">
<location>
<begin position="764"/>
<end position="813"/>
</location>
</feature>
<feature type="domain" description="Laminin EGF-like 3" evidence="10">
<location>
<begin position="814"/>
<end position="871"/>
</location>
</feature>
<feature type="domain" description="Laminin EGF-like 4; truncated" evidence="10">
<location>
<begin position="879"/>
<end position="923"/>
</location>
</feature>
<feature type="domain" description="Laminin EGF-like 5; first part" evidence="10">
<location>
<begin position="924"/>
<end position="933"/>
</location>
</feature>
<feature type="domain" description="Laminin IV type A 2" evidence="9">
<location>
<begin position="941"/>
<end position="1125"/>
</location>
</feature>
<feature type="domain" description="Laminin EGF-like 5; second part" evidence="10">
<location>
<begin position="1126"/>
<end position="1158"/>
</location>
</feature>
<feature type="domain" description="Laminin EGF-like 6" evidence="10">
<location>
<begin position="1159"/>
<end position="1208"/>
</location>
</feature>
<feature type="domain" description="Laminin EGF-like 7" evidence="10">
<location>
<begin position="1209"/>
<end position="1265"/>
</location>
</feature>
<feature type="domain" description="Laminin EGF-like 8" evidence="10">
<location>
<begin position="1275"/>
<end position="1324"/>
</location>
</feature>
<feature type="domain" description="Laminin EGF-like 9; first part" evidence="10">
<location>
<begin position="1325"/>
<end position="1334"/>
</location>
</feature>
<feature type="domain" description="Laminin IV type A 3" evidence="9">
<location>
<begin position="1344"/>
<end position="1529"/>
</location>
</feature>
<feature type="domain" description="Laminin EGF-like 9; second part" evidence="10">
<location>
<begin position="1530"/>
<end position="1562"/>
</location>
</feature>
<feature type="domain" description="Laminin EGF-like 10" evidence="10">
<location>
<begin position="1563"/>
<end position="1612"/>
</location>
</feature>
<feature type="domain" description="Laminin EGF-like 11" evidence="10">
<location>
<begin position="1613"/>
<end position="1670"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 2">
<location>
<begin position="1677"/>
<end position="1771"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 3">
<location>
<begin position="1772"/>
<end position="1865"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 4">
<location>
<begin position="1866"/>
<end position="1955"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 5">
<location>
<begin position="1956"/>
<end position="2051"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 6">
<location>
<begin position="2052"/>
<end position="2151"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 7">
<location>
<begin position="2152"/>
<end position="2244"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 8">
<location>
<begin position="2245"/>
<end position="2340"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 9">
<location>
<begin position="2341"/>
<end position="2436"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 10">
<location>
<begin position="2437"/>
<end position="2533"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 11">
<location>
<begin position="2534"/>
<end position="2629"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 12">
<location>
<begin position="2630"/>
<end position="2726"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 13">
<location>
<begin position="2727"/>
<end position="2826"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 14">
<location>
<begin position="2827"/>
<end position="2924"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 15">
<location>
<begin position="2925"/>
<end position="3021"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 16">
<location>
<begin position="3022"/>
<end position="3112"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 17">
<location>
<begin position="3113"/>
<end position="3211"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 18">
<location>
<begin position="3212"/>
<end position="3298"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 19">
<location>
<begin position="3299"/>
<end position="3399"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 20">
<location>
<begin position="3400"/>
<end position="3488"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 21">
<location>
<begin position="3489"/>
<end position="3574"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 22">
<location>
<begin position="3575"/>
<end position="3662"/>
</location>
</feature>
<feature type="domain" description="Laminin G-like 1" evidence="6">
<location>
<begin position="3663"/>
<end position="3843"/>
</location>
</feature>
<feature type="domain" description="EGF-like 1" evidence="5">
<location>
<begin position="3844"/>
<end position="3881"/>
</location>
</feature>
<feature type="domain" description="EGF-like 2" evidence="5">
<location>
<begin position="3884"/>
<end position="3922"/>
</location>
</feature>
<feature type="domain" description="Laminin G-like 2" evidence="6">
<location>
<begin position="3928"/>
<end position="4103"/>
</location>
</feature>
<feature type="domain" description="EGF-like 3" evidence="5">
<location>
<begin position="4104"/>
<end position="4141"/>
</location>
</feature>
<feature type="domain" description="EGF-like 4" evidence="5">
<location>
<begin position="4143"/>
<end position="4176"/>
</location>
</feature>
<feature type="domain" description="Laminin G-like 3" evidence="6">
<location>
<begin position="4201"/>
<end position="4389"/>
</location>
</feature>
<feature type="region of interest" description="Mediates motor neuron attachment" evidence="4">
<location>
<begin position="4149"/>
<end position="4151"/>
</location>
</feature>
<feature type="region of interest" description="Mediates motor neuron attachment" evidence="4">
<location>
<begin position="4299"/>
<end position="4301"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Calcium">
<location>
<position position="4258"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Calcium; via carbonyl oxygen">
<location>
<position position="4275"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Calcium; via carbonyl oxygen">
<location>
<position position="4325"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Calcium">
<location>
<position position="4327"/>
</location>
</feature>
<feature type="site" description="Cleavage; by BMP1">
<location>
<begin position="4196"/>
<end position="4197"/>
</location>
</feature>
<feature type="glycosylation site" description="O-linked (GalNAc...) threonine" evidence="24">
<location>
<position position="42"/>
</location>
</feature>
<feature type="glycosylation site" description="O-linked (Xyl...) (heparan sulfate) serine" evidence="4">
<location>
<position position="65"/>
</location>
</feature>
<feature type="glycosylation site" description="O-linked (Xyl...) (heparan sulfate) serine" evidence="4">
<location>
<position position="71"/>
</location>
</feature>
<feature type="glycosylation site" description="O-linked (Xyl...) (heparan sulfate) serine" evidence="4">
<location>
<position position="76"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="89"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="22">
<location>
<position position="554"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="20 22">
<location>
<position position="1755"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="17">
<location>
<position position="2121"/>
</location>
</feature>
<feature type="glycosylation site" description="O-linked (Xyl...) (chondroitin sulfate) serine" evidence="4">
<location>
<position position="2995"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="22">
<location>
<position position="3072"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="3105"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4">
<location>
<position position="3279"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="22">
<location>
<position position="3780"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="22">
<location>
<position position="3836"/>
</location>
</feature>
<feature type="glycosylation site" description="O-linked (Xyl...) (chondroitin sulfate) serine" evidence="4">
<location>
<position position="3933"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="22">
<location>
<position position="4068"/>
</location>
</feature>
<feature type="glycosylation site" description="O-linked (Xyl...) (chondroitin sulfate) serine" evidence="4">
<location>
<position position="4179"/>
</location>
</feature>
<feature type="disulfide bond" evidence="3">
<location>
<begin position="199"/>
<end position="212"/>
</location>
</feature>
<feature type="disulfide bond" evidence="3">
<location>
<begin position="206"/>
<end position="225"/>
</location>
</feature>
<feature type="disulfide bond" evidence="3">
<location>
<begin position="219"/>
<end position="234"/>
</location>
</feature>
<feature type="disulfide bond" evidence="3">
<location>
<begin position="285"/>
<end position="297"/>
</location>
</feature>
<feature type="disulfide bond" evidence="3">
<location>
<begin position="292"/>
<end position="310"/>
</location>
</feature>
<feature type="disulfide bond" evidence="3">
<location>
<begin position="304"/>
<end position="319"/>
</location>
</feature>
<feature type="disulfide bond" evidence="3">
<location>
<begin position="325"/>
<end position="337"/>
</location>
</feature>
<feature type="disulfide bond" evidence="3">
<location>
<begin position="332"/>
<end position="350"/>
</location>
</feature>
<feature type="disulfide bond" evidence="3">
<location>
<begin position="344"/>
<end position="359"/>
</location>
</feature>
<feature type="disulfide bond" evidence="3">
<location>
<begin position="368"/>
<end position="381"/>
</location>
</feature>
<feature type="disulfide bond" evidence="3">
<location>
<begin position="375"/>
<end position="394"/>
</location>
</feature>
<feature type="disulfide bond" evidence="3">
<location>
<begin position="388"/>
<end position="403"/>
</location>
</feature>
<feature type="disulfide bond" evidence="3">
<location>
<begin position="764"/>
<end position="773"/>
</location>
</feature>
<feature type="disulfide bond" evidence="3">
<location>
<begin position="766"/>
<end position="780"/>
</location>
</feature>
<feature type="disulfide bond" evidence="3">
<location>
<begin position="783"/>
<end position="792"/>
</location>
</feature>
<feature type="disulfide bond" evidence="3">
<location>
<begin position="795"/>
<end position="811"/>
</location>
</feature>
<feature type="disulfide bond" evidence="3">
<location>
<begin position="814"/>
<end position="829"/>
</location>
</feature>
<feature type="disulfide bond" evidence="3">
<location>
<begin position="816"/>
<end position="839"/>
</location>
</feature>
<feature type="disulfide bond" evidence="3">
<location>
<begin position="842"/>
<end position="851"/>
</location>
</feature>
<feature type="disulfide bond" evidence="3">
<location>
<begin position="854"/>
<end position="869"/>
</location>
</feature>
<feature type="disulfide bond" evidence="3">
<location>
<begin position="879"/>
<end position="892"/>
</location>
</feature>
<feature type="disulfide bond" evidence="3">
<location>
<begin position="894"/>
<end position="903"/>
</location>
</feature>
<feature type="disulfide bond" evidence="3">
<location>
<begin position="906"/>
<end position="921"/>
</location>
</feature>
<feature type="disulfide bond" evidence="3">
<location>
<begin position="1159"/>
<end position="1168"/>
</location>
</feature>
<feature type="disulfide bond" evidence="3">
<location>
<begin position="1161"/>
<end position="1175"/>
</location>
</feature>
<feature type="disulfide bond" evidence="3">
<location>
<begin position="1178"/>
<end position="1187"/>
</location>
</feature>
<feature type="disulfide bond" evidence="3">
<location>
<begin position="1190"/>
<end position="1206"/>
</location>
</feature>
<feature type="disulfide bond" evidence="3">
<location>
<begin position="1209"/>
<end position="1224"/>
</location>
</feature>
<feature type="disulfide bond" evidence="3">
<location>
<begin position="1211"/>
<end position="1234"/>
</location>
</feature>
<feature type="disulfide bond" evidence="3">
<location>
<begin position="1237"/>
<end position="1246"/>
</location>
</feature>
<feature type="disulfide bond" evidence="3">
<location>
<begin position="1249"/>
<end position="1263"/>
</location>
</feature>
<feature type="disulfide bond" evidence="3">
<location>
<begin position="1275"/>
<end position="1287"/>
</location>
</feature>
<feature type="disulfide bond" evidence="3">
<location>
<begin position="1277"/>
<end position="1293"/>
</location>
</feature>
<feature type="disulfide bond" evidence="3">
<location>
<begin position="1295"/>
<end position="1304"/>
</location>
</feature>
<feature type="disulfide bond" evidence="3">
<location>
<begin position="1307"/>
<end position="1322"/>
</location>
</feature>
<feature type="disulfide bond" evidence="3">
<location>
<begin position="1563"/>
<end position="1572"/>
</location>
</feature>
<feature type="disulfide bond" evidence="3">
<location>
<begin position="1565"/>
<end position="1579"/>
</location>
</feature>
<feature type="disulfide bond" evidence="3">
<location>
<begin position="1582"/>
<end position="1591"/>
</location>
</feature>
<feature type="disulfide bond" evidence="3">
<location>
<begin position="1594"/>
<end position="1610"/>
</location>
</feature>
<feature type="disulfide bond" evidence="3">
<location>
<begin position="1613"/>
<end position="1628"/>
</location>
</feature>
<feature type="disulfide bond" evidence="3">
<location>
<begin position="1615"/>
<end position="1638"/>
</location>
</feature>
<feature type="disulfide bond" evidence="3">
<location>
<begin position="1641"/>
<end position="1650"/>
</location>
</feature>
<feature type="disulfide bond" evidence="3">
<location>
<begin position="1653"/>
<end position="1668"/>
</location>
</feature>
<feature type="disulfide bond" evidence="3">
<location>
<begin position="3819"/>
<end position="3845"/>
</location>
</feature>
<feature type="disulfide bond" evidence="3">
<location>
<begin position="3848"/>
<end position="3859"/>
</location>
</feature>
<feature type="disulfide bond" evidence="3">
<location>
<begin position="3853"/>
<end position="3869"/>
</location>
</feature>
<feature type="disulfide bond" evidence="3">
<location>
<begin position="3871"/>
<end position="3880"/>
</location>
</feature>
<feature type="disulfide bond" evidence="3">
<location>
<begin position="3888"/>
<end position="3899"/>
</location>
</feature>
<feature type="disulfide bond" evidence="3">
<location>
<begin position="3893"/>
<end position="3910"/>
</location>
</feature>
<feature type="disulfide bond" evidence="3">
<location>
<begin position="3912"/>
<end position="3921"/>
</location>
</feature>
<feature type="disulfide bond" evidence="3">
<location>
<begin position="4076"/>
<end position="4102"/>
</location>
</feature>
<feature type="disulfide bond" evidence="3">
<location>
<begin position="4108"/>
<end position="4119"/>
</location>
</feature>
<feature type="disulfide bond" evidence="3">
<location>
<begin position="4113"/>
<end position="4129"/>
</location>
</feature>
<feature type="disulfide bond" evidence="3">
<location>
<begin position="4131"/>
<end position="4140"/>
</location>
</feature>
<feature type="disulfide bond" evidence="3">
<location>
<begin position="4147"/>
<end position="4159"/>
</location>
</feature>
<feature type="disulfide bond" evidence="3">
<location>
<begin position="4153"/>
<end position="4164"/>
</location>
</feature>
<feature type="disulfide bond" evidence="3">
<location>
<begin position="4166"/>
<end position="4175"/>
</location>
</feature>
<feature type="disulfide bond" evidence="23">
<location>
<begin position="4355"/>
<end position="4389"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1869780." id="VAR_047979">
<original>D</original>
<variation>E</variation>
<location>
<position position="68"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs17460381." id="VAR_057051">
<original>L</original>
<variation>H</variation>
<location>
<position position="303"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1874792." id="VAR_047980" evidence="11 19 21">
<original>M</original>
<variation>V</variation>
<location>
<position position="638"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs989994." id="VAR_047981" evidence="11 19 21">
<original>N</original>
<variation>S</variation>
<location>
<position position="765"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs2229481." id="VAR_047982">
<original>R</original>
<variation>Q</variation>
<location>
<position position="1186"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs10917058." id="VAR_057052">
<original>L</original>
<variation>V</variation>
<location>
<position position="1323"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs897471." id="VAR_047983" evidence="11 19 21">
<original>A</original>
<variation>V</variation>
<location>
<position position="1503"/>
</location>
</feature>
<feature type="sequence variant" description="In SJS1; dbSNP:rs137853248." id="VAR_014122" evidence="11">
<original>C</original>
<variation>Y</variation>
<location>
<position position="1532"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs2229483." id="VAR_047984">
<original>R</original>
<variation>Q</variation>
<location>
<position position="1758"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs2229474." id="VAR_047985">
<original>R</original>
<variation>C</variation>
<location>
<position position="1919"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs2229475." id="VAR_047986">
<original>V</original>
<variation>I</variation>
<location>
<position position="1967"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs2229489." id="VAR_047987" evidence="21">
<original>L</original>
<variation>H</variation>
<location>
<position position="2980"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs2229490." id="VAR_047988">
<original>V</original>
<variation>I</variation>
<location>
<position position="2981"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs2229491." id="VAR_047989" evidence="21">
<original>S</original>
<variation>G</variation>
<location>
<position position="2995"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs2228349." id="VAR_047990" evidence="21">
<original>A</original>
<variation>T</variation>
<location>
<position position="3168"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs2291827." id="VAR_047991">
<original>H</original>
<variation>Y</variation>
<location>
<position position="3256"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs2270699." id="VAR_047992">
<original>R</original>
<variation>W</variation>
<location>
<position position="3530"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs2229493." id="VAR_047993" evidence="21">
<original>R</original>
<variation>Q</variation>
<location>
<position position="3632"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs17459097." id="VAR_047994">
<original>V</original>
<variation>I</variation>
<location>
<position position="3640"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs3736360." id="VAR_047995">
<original>S</original>
<variation>N</variation>
<location>
<position position="4331"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes BMP1-mediated cleavage of endorepellin." evidence="18">
<original>D</original>
<variation>I</variation>
<location>
<position position="4197"/>
</location>
</feature>
<feature type="mutagenesis site" description="Retains proper folding. Reduced calcium ion binding." evidence="18">
<original>D</original>
<variation>A</variation>
<location>
<position position="4258"/>
</location>
</feature>
<feature type="mutagenesis site" description="Retains proper folding. Reduced calcium ion binding." evidence="18">
<original>N</original>
<variation>A</variation>
<location>
<position position="4327"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; CAA44373 and 1; AAA52700." ref="2 1" evidence="25">
<original>A</original>
<variation>P</variation>
<location>
<position position="6"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAA52700." ref="1" evidence="25">
<original>D</original>
<variation>Y</variation>
<location>
<position position="58"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; CAA44373." ref="2" evidence="25">
<original>TPI</original>
<variation>APFL</variation>
<location>
<begin position="435"/>
<end position="437"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; CAA44373." ref="2" evidence="25">
<original>H</original>
<variation>Q</variation>
<location>
<position position="450"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; CAA44373." ref="2" evidence="25">
<original>R</original>
<variation>RA</variation>
<location>
<position position="502"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; CAA44373." ref="2" evidence="25">
<original>N</original>
<variation>K</variation>
<location>
<position position="793"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 6; AAB21121." ref="6" evidence="25">
<original>EA</original>
<variation>RT</variation>
<location>
<begin position="890"/>
<end position="891"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; CAA44373 and 6; AAB21121." ref="2 6" evidence="25">
<original>G</original>
<variation>R</variation>
<location>
<position position="909"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 6; AAB21121." ref="6" evidence="25">
<original>V</original>
<variation>L</variation>
<location>
<position position="1102"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 6; AAB21121." ref="6" evidence="25">
<original>R</original>
<variation>L</variation>
<location>
<position position="1133"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 6; AAB21121." ref="6" evidence="25">
<original>H</original>
<variation>L</variation>
<location>
<position position="1222"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 7; AAA52699." ref="7" evidence="25">
<original>D</original>
<variation>G</variation>
<location>
<position position="1406"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 7; AAA52699." ref="7" evidence="25">
<original>A</original>
<variation>G</variation>
<location>
<position position="1410"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 7; AAA52699." ref="7" evidence="25">
<original>EFWRR</original>
<variation>LNLRQ</variation>
<location>
<begin position="1466"/>
<end position="1470"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; CAA44373." ref="2" evidence="25">
<original>SP</original>
<variation>RG</variation>
<location>
<begin position="1703"/>
<end position="1704"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; CAA44373." ref="2" evidence="25">
<original>Q</original>
<variation>R</variation>
<location>
<position position="1753"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAA52700." ref="1" evidence="25">
<original>I</original>
<variation>M</variation>
<location>
<position position="2038"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; CAA44373." ref="2" evidence="25">
<original>P</original>
<variation>Q</variation>
<location>
<position position="2050"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAA52700." ref="1" evidence="25">
<original>P</original>
<variation>G</variation>
<location>
<position position="2052"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; CAA44373." ref="2" evidence="25">
<original>P</original>
<variation>H</variation>
<location>
<position position="2093"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; CAA44373." ref="2" evidence="25">
<original>S</original>
<variation>R</variation>
<location>
<position position="2627"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; CAA44373." ref="2" evidence="25">
<original>H</original>
<variation>Y</variation>
<location>
<position position="2770"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; CAA44373." ref="2" evidence="25">
<original>P</original>
<variation>R</variation>
<location>
<position position="3241"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAA52700." ref="1" evidence="25">
<original>R</original>
<variation>Q</variation>
<location>
<position position="3427"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; CAA44373." ref="2" evidence="25">
<original>S</original>
<variation>T</variation>
<location>
<position position="4004"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; CAA44373." ref="2" evidence="25">
<original>F</original>
<variation>I</variation>
<location>
<position position="4135"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; CAA44373." ref="2" evidence="25">
<original>V</original>
<variation>I</variation>
<location>
<position position="4332"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="4199"/>
<end position="4202"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="4203"/>
<end position="4214"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="4216"/>
<end position="4219"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="4228"/>
<end position="4236"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="4239"/>
<end position="4246"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="4259"/>
<end position="4265"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="4268"/>
<end position="4274"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="4279"/>
<end position="4283"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="4290"/>
<end position="4292"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="4294"/>
<end position="4301"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="4304"/>
<end position="4309"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="4315"/>
<end position="4318"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="4320"/>
<end position="4322"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="4332"/>
<end position="4335"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="4340"/>
<end position="4343"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="4344"/>
<end position="4346"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="4353"/>
<end position="4363"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="4366"/>
<end position="4368"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="4376"/>
<end position="4378"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="4381"/>
<end position="4388"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3SH4"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3SH5"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000250"/>
<evidence key="4" type="ECO:0000255"/>
<evidence key="5" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00076"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00122"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00124"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00188"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00458"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00460"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11101850"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11148217"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11279527"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11956183"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12435733"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12604605"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12754519"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15591058"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1569102"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16335952"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1730768"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19159218"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21996443"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22171320"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000305"/>
<sequence length="4391" mass="468830" checksum="C587660E24C83324" modified="2011-01-11" version="4" precursor="true">
MGWRAAGALLLALLLHGRLLAVTHGLRAYDGLSLPEDIETVTASQMRWTHSYLSDDEDML
ADSISGDDLGSGDLGSGDFQMVYFRALVNFTRSIEYSPQLEDAGSREFREVSEAVVDTLE
SEYLKIPGDQVVSVVFIKELDGWVFVELDVGSEGNADGAQIQEMLLRVISSGSVASYVTS
PQGFQFRRLGTVPQFPRACTEAEFACHSYNECVALEYRCDRRPDCRDMSDELNCEEPVLG
ISPTFSLLVETTSLPPRPETTIMRQPPVTHAPQPLLPGSVRPLPCGPQEAACRNGHCIPR
DYLCDGQEDCEDGSDELDCGPPPPCEPNEFPCGNGHCALKLWRCDGDFDCEDRTDEANCP
TKRPEEVCGPTQFRCVSTNMCIPASFHCDEESDCPDRSDEFGCMPPQVVTPPRESIQASR
GQTVTFTCVAIGVPTPIINWRLNWGHIPSHPRVTVTSEGGRGTLIIRDVKESDQGAYTCE
AMNARGMVFGIPDGVLELVPQRGPCPDGHFYLEHSAACLPCFCFGITSVCQSTRRFRDQI
RLRFDQPDDFKGVNVTMPAQPGTPPLSSTQLQIDPSLHEFQLVDLSRRFLVHDSFWALPE
QFLGNKVDSYGGSLRYNVRYELARGMLEPVQRPDVVLMGAGYRLLSRGHTPTQPGALNQR
QVQFSEEHWVHESGRPVQRAELLQVLQSLEAVLIQTVYNTKMASVGLSDIAMDTTVTHAT
SHGRAHSVEECRCPIGYSGLSCESCDAHFTRVPGGPYLGTCSGCNCNGHASSCDPVYGHC
LNCQHNTEGPQCNKCKAGFFGDAMKATATSCRPCPCPYIDASRRFSDTCFLDTDGQATCD
ACAPGYTGRRCESCAPGYEGNPIQPGGKCRPVNQEIVRCDERGSMGTSGEACRCKNNVVG
RLCNECADGSFHLSTRNPDGCLKCFCMGVSRHCTSSSWSRAQLHGASEEPGHFSLTNAAS
THTTNEGIFSPTPGELGFSSFHRLLSGPYFWSLPSRFLGDKVTSYGGELRFTVTQRSQPG
STPLHGQPLVVLQGNNIILEHHVAQEPSPGQPSTFIVPFREQAWQRPDGQPATREHLLMA
LAGIDTLLIRASYAQQPAESRVSGISMDVAVPEETGQDPALEVEQCSCPPGYRGPSCQDC
DTGYTRTPSGLYLGTCERCSCHGHSEACEPETGACQGCQHHTEGPRCEQCQPGYYGDAQR
GTPQDCQLCPCYGDPAAGQAAHTCFLDTDGHPTCDACSPGHSGRHCERCAPGYYGNPSQG
QPCQRDSQVPGPIGCNCDPQGSVSSQCDAAGQCQCKAQVEGLTCSHCRPHHFHLSASNPD
GCLPCFCMGITQQCASSAYTRHLISTHFAPGDFQGFALVNPQRNSRLTGEFTVEPVPEGA
QLSFGNFAQLGHESFYWQLPETYQGDKVAAYGGKLRYTLSYTAGPQGSPLSDPDVQITGN
NIMLVASQPALQGPERRSYEIMFREEFWRRPDGQPATREHLLMALADLDELLIRATFSSV
PLAASISAVSLEVAQPGPSNRPRALEVEECRCPPGYIGLSCQDCAPGYTRTGSGLYLGHC
ELCECNGHSDLCHPETGACSQCQHNAAGEFCELCAPGYYGDATAGTPEDCQPCACPLTNP
ENMFSRTCESLGAGGYRCTACEPGYTGQYCEQCGPGYVGNPSVQGGQCLPETNQAPLVVE
VHPARSIVPQGGSHSLRCQVSGSPPHYFYWSREDGRPVPSGTQQRHQGSELHFPSVQPSD
AGVYICTCRNLHQSNTSRAELLVTEAPSKPITVTVEEQRSQSVRPGADVTFICTAKSKSP
AYTLVWTRLHNGKLPTRAMDFNGILTIRNVQLSDAGTYVCTGSNMFAMDQGTATLHVQAS
GTLSAPVVSIHPPQLTVQPGQLAEFRCSATGSPTPTLEWTGGPGGQLPAKAQIHGGILRL
PAVEPTDQAQYLCRAHSSAGQQVARAVLHVHGGGGPRVQVSPERTQVHAGRTVRLYCRAA
GVPSATITWRKEGGSLPPQARSERTDIATLLIPAITTADAGFYLCVATSPAGTAQARIQV
VVLSASDASPPPVKIESSSPSVTEGQTLDLNCVVAGSAHAQVTWYRRGGSLPPHTQVHGS
RLRLPQVSPADSGEYVCRVENGSGPKEASITVSVLHGTHSGPSYTPVPGSTRPIRIEPSS
SHVAEGQTLDLNCVVPGQAHAQVTWHKRGGSLPARHQTHGSLLRLHQVTPADSGEYVCHV
VGTSGPLEASVLVTIEASVIPGPIPPVRIESSSSTVAEGQTLDLSCVVAGQAHAQVTWYK
RGGSLPARHQVRGSRLYIFQASPADAGQYVCRASNGMEASITVTVTGTQGANLAYPAGST
QPIRIEPSSSQVAEGQTLDLNCVVPGQSHAQVTWHKRGGSLPVRHQTHGSLLRLYQASPA
DSGEYVCRVLGSSVPLEASVLVTIEPAGSVPALGVTPTVRIESSSSQVAEGQTLDLNCLV
AGQAHAQVTWHKRGGSLPARHQVHGSRLRLLQVTPADSGEYVCRVVGSSGTQEASVLVTI
QQRLSGSHSQGVAYPVRIESSSASLANGHTLDLNCLVASQAPHTITWYKRGGSLPSRHQI
VGSRLRIPQVTPADSGEYVCHVSNGAGSRETSLIVTIQGSGSSHVPSVSPPIRIESSSPT
VVEGQTLDLNCVVARQPQAIITWYKRGGSLPSRHQTHGSHLRLHQMSVADSGEYVCRANN
NIDALEASIVISVSPSAGSPSAPGSSMPIRIESSSSHVAEGETLDLNCVVPGQAHAQVTW
HKRGGSLPSHHQTRGSRLRLHHVSPADSGEYVCRVMGSSGPLEASVLVTIEASGSSAVHV
PAPGGAPPIRIEPSSSRVAEGQTLDLKCVVPGQAHAQVTWHKRGGNLPARHQVHGPLLRL
NQVSPADSGEYSCQVTGSSGTLEASVLVTIEPSSPGPIPAPGLAQPIYIEASSSHVTEGQ
TLDLNCVVPGQAHAQVTWYKRGGSLPARHQTHGSQLRLHLVSPADSGEYVCRAASGPGPE
QEASFTVTVPPSEGSSYRLRSPVISIDPPSSTVQQGQDASFKCLIHDGAAPISLEWKTRN
QELEDNVHISPNGSIITIVGTRPSNHGTYRCVASNAYGVAQSVVNLSVHGPPTVSVLPEG
PVWVKVGKAVTLECVSAGEPRSSARWTRISSTPAKLEQRTYGLMDSHAVLQISSAKPSDA
GTYVCLAQNALGTAQKQVEVIVDTGAMAPGAPQVQAEEAELTVEAGHTATLRCSATGSPA
PTIHWSKLRSPLPWQHRLEGDTLIIPRVAQQDSGQYICNATSPAGHAEATIILHVESPPY
ATTVPEHASVQAGETVQLQCLAHGTPPLTFQWSRVGSSLPGRATARNELLHFERAAPEDS
GRYRCRVTNKVGSAEAFAQLLVQGPPGSLPATSIPAGSTPTVQVTPQLETKSIGASVEFH
CAVPSDRGTQLRWFKEGGQLPPGHSVQDGVLRIQNLDQSCQGTYICQAHGPWGKAQASAQ
LVIQALPSVLINIRTSVQTVVVGHAVEFECLALGDPKPQVTWSKVGGHLRPGIVQSGGVV
RIAHVELADAGQYRCTATNAAGTTQSHVLLLVQALPQISMPQEVRVPAGSAAVFPCIASG
YPTPDISWSKLDGSLPPDSRLENNMLMLPSVRPQDAGTYVCTATNRQGKVKAFAHLQVPE
RVVPYFTQTPYSFLPLPTIKDAYRKFEIKITFRPDSADGMLLYNGQKRVPGSPTNLANRQ
PDFISFGLVGGRPEFRFDAGSGMATIRHPTPLALGHFHTVTLLRSLTQGSLIVGDLAPVN
GTSQGKFQGLDLNEELYLGGYPDYGAIPKAGLSSGFIGCVRELRIQGEEIVFHDLNLTAH
GISHCPTCRDRPCQNGGQCHDSESSSYVCVCPAGFTGSRCEHSQALHCHPEACGPDATCV
NRPDGRGYTCRCHLGRSGLRCEEGVTVTTPSLSGAGSYLALPALTNTHHELRLDVEFKPL
APDGVLLFSGGKSGPVEDFVSLAMVGGHLEFRYELGSGLAVLRSAEPLALGRWHRVSAER
LNKDGSLRVNGGRPVLRSSPGKSQGLNLHTLLYLGGVEPSVPLSPATNMSAHFRGCVGEV
SVNGKRLDLTYSFLGSQGIGQCYDSSPCERQPCQHGATCMPAGEYEFQCLCRDGFKGDLC
EHEENPCQLREPCLHGGTCQGTRCLCLPGFSGPRCQQGSGHGIAESDWHLEGSGGNDAPG
QYGAYFHDDGFLAFPGHVFSRSLPEVPETIELEVRTSTASGLLLWQGVEVGEAGQGKDFI
SLGLQDGHLVFRYQLGSGEARLVSEDPINDGEWHRVTALREGRRGSIQVDGEELVSGRSP
GPNVAVNAKGSVYIGGAPDVATLTGGRFSSGITGCVKNLVLHSARPGAPPPQPLDLQHRA
QAGANTRPCPS
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>